NCT05480995View on ClinicalTrials.gov

Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI

PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 17, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Endometriosis
Interventions
DRUG

18F-fluorofuranylnorprogesterone PET / MRI

Subjects will receive a PET/MRI with 18F-fluorofuranylnorprogesterone tracer

Trial Locations (1)

27599

RECRUITING

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of North Carolina, Chapel Hill

OTHER